Hosted on MSN

AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’

Shares of AbbVie Inc. (ABBV) hit a fresh record high on Thursday before paring back some of the gains, after the company said it does not expect any generic versions of its Rinvoq in the U.S. before ...
Barron's

AbbVie Stock Hit a Record on ‘Big Win’ for Blockbuster Drug. The Case for Buying In.

Shares of AbbVie closed at a record after it struck a deal that will extend patent exclusivity for its blockbuster autoimmune medicine Rinvoq until 2037. Wall Street analyst say the stock might still ...
FiercePharma

AbbVie jacks up 2027 sales projection for star duo of Skyrizi, Rinvoq to $31B

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started and How it’s Going” memes are looking better each quarter for the Illinois drugmaker. On Friday, when AbbVie ...
Wall Street Journal

AbbVie in Settlement With Generic Drugmakers on Rinvoq

AbbVie ABBV-3.20%decrease; red down pointing triangle has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq well into the next ...